// App-Quantinova.ai

2269 : Epidemiological Data On the Incidence of Co-Morbidities and Co-Medications in Patients Undergoing Total Hip or Knee Replacement Surgery: Real-World Study and Phase III Clinical Trials.

Researchers

Presenter

  • Simon Frostick

Principal Investigators

  • Charles Marc Samama

  • Martin Feuring

  • Eva Kleine

  • Martina Brueckmann

  • Andreas Clemens

Medical Centers

  • Musculoskeletal Science Research Group, Department of Molecular & Clinical Cancer Medicine, Royal Liverpool University Hospital, Liverpool, United Kingdom

  • Department of Anaesthesia and Intensive Care Medicine, Cochin University Hospital, Paris, France

Locations

  • France

  • United Kingdom

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Creatinine

  • Transketolase Like 1

  • Body mass index

Drug/Treatment

  • Albyl-E

  • Pradax

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A


Study Design

  • single arm

  • observational

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim